Expanded GGGGCC Hexanucleotide Repeat in Noncoding Region of C9ORF72 Causes Chromosome 9p-Linked FTD and ALS

Cited by (1,058)

Items 601–700 of 1,058

1. Psychiatric Symptoms in Frontotemporal Dementia: Epidemiology, Phenotypes, and Differential Diagnosis
   Daniela Galimberti, Bernardo Maria Dell’Osso, A. Carlo Altamura, Elio Angelo Scarpini · 2015 · Biological Psychiatry
2. Autophagosome dynamics in neurodegeneration at a glance
   Yvette C. Wong, Erika L.F. Holzbaur · 2015 · Journal of Cell Science
3. Hexanucleotide repeat expansions in C9ORF72 in the spectrum of motor neuron diseases
   Wouter van Rheenen, Marka van Blitterswijk, Mark H.B. Huisman, Lotte Vlam, Perry T.C. van Doormaal, Meinie Seelen, Jelena Medic, Dennis Dooijes, Marianne de Visser, Anneke J. van der Kooi et al. · 2012 · Neurology
4. Stress granule subtypes: an emerging link to neurodegeneration
   Vivek M. Advani, Pavel V. Ivanov · 2020 · Cellular and Molecular Life Sciences
5. The TRK-Fused Gene Is Mutated in Hereditary Motor and Sensory Neuropathy with Proximal Dominant Involvement
   Hiroyuki Ishiura, Wataru Sako, Mari Yoshida, Toshitaka Kawarai, Osamu Tanabe, Jun Goto, Yuji Takahashi, Hidetoshi Date, Jun Mitsui, Budrul Ahsan et al. · 2012 · The American Journal of Human Genetics
6. Protein Kinase CK-1 Inhibitors As New Potential Drugs for Amyotrophic Lateral Sclerosis
   Irene G. Salado, Miriam Redondo, Murilo Lamim Bello, Concepción Pérez, Nicole F. Liachko, Brian C. Kraemer, Laëtitia Miguel, Magalie Lecourtois, Carmen Gil, Ana Martı́nez et al. · 2014 · Journal of Medicinal Chemistry
7. Genome-wide analyses as part of the international FTLD-TDP whole-genome sequencing consortium reveals novel disease risk factors and increases support for immune dysfunction in FTLD
   Cyril P. Pottier, Yingxue Ren, Ralph B. Perkerson, Matt C. Baker, Gregory D. Jenkins, Marka van Blitterswijk, Mariely DeJesus‐Hernandez, Jeroen van Rooij, Melissa Erin Murray, Elizabeth A. Christopher et al. · 2019 · Acta Neuropathologica
8. Short Tandem Repeat Expansions and RNA-Mediated Pathogenesis in Myotonic Dystrophy
   Łukasz J. Sznajder, Maurice S. Swanson · 2019 · International Journal of Molecular Sciences
9. Diseases of the nERVous system: retrotransposon activity in neurodegenerative disease
   Oliver H. Tam, Lyle W. Ostrow, Molly Hammell · 2019 · Mobile DNA
10. The role of hnRNPs in frontotemporal dementia and amyotrophic lateral sclerosis
    Alexander Bampton, Lauren M. Gittings, Pietro Fratta, Tammaryn Lashley, Ariana P. Gatt · 2020 · Acta Neuropathologica
11. Nuclear Import Receptors Directly Bind to Arginine-Rich Dipeptide Repeat Proteins and Suppress Their Pathological Interactions
    Saskia Hutten, Sinem Usluer, Benjamin M. R. Bourgeois, Francesca Simonetti, Hana M. Odeh, Charlotte M. Fare, Mareike Czuppa, Marián Hruška-Plocháň, Mario Hofweber, Magdalini Polymenidou et al. · 2020 · Cell Reports
12. ER Stress-Sensor Proteins and ER-Mitochondrial Crosstalk—Signaling Beyond (ER) Stress Response
    Vaishali Kumar, Shuvadeep Maity · 2021 · Biomolecules
13. STING trafficking as a new dimension of immune signaling
    Devon Jeltema, Kennady Abbott, Nan Yan · 2023 · The Journal of Experimental Medicine
14. Dysfunction of Optineurin in Amyotrophic Lateral Sclerosis and Glaucoma
    Toth, Reka P., Atkin, Julie D. · 2018 · Frontiers in Immunology
15. Wild type human TDP-43 potentiates ALS-linked mutant TDP-43 driven progressive motor and cortical neuron degeneration with pathological features of ALS
    Jacqueline C. Mitchell, Remy Constable, Eva So, Caroline A. Vance, Emma L. Scotter, Leanne Glover, Tibor Hortobágyi, Eveline S. Arnold, Shuo‐Chien Ling, Melissa McAlonis‐Downes et al. · 2015 · Acta Neuropathologica Communications
16. The ER mitochondria calcium cycle and ER stress response as therapeutic targets in amyotrophic lateral sclerosis
    Vedrana Tadić, Tino Prell, Janin Lautenschläger, Julian Großkreutz · 2014 · Frontiers in Cellular Neuroscience
17. Mouse models of ALS: Past, present and future
    Cathleen M. Lutz · 2018 · Brain Research
18. Contribution of astrocytes to neuropathology of neurodegenerative diseases
    Çiğdem Acıoğlu, Lun Li, Stella Elkabes · 2021 · Brain Research
19. RNA methylation influences TDP43 binding and disease pathogenesis in models of amyotrophic lateral sclerosis and frontotemporal dementia
    McMillan, Michael, Gomez, Nicolas, Hsieh, Caroline, Bekier, Michael, Li, Xingli, Miguez, Roberto, Tank, Elizabeth M.H., Barmada, Sami J. · 2023 · Molecular Cell
20. Effects of tofersen treatment in patients with SOD1-ALS in a “real-world” setting – a 12-month multicenter cohort study from the German early access program
    Maximilian Wiesenfarth, Johannes Dorst, Dávid Brenner, Zeynep G. Elmas, Özlem Parlak, Željko Uzelac, Katharina Kandler, Kristina Mayer, Ulrike Weiland, Christine H. Herrmann et al. · 2024 · EClinicalMedicine
21. Neuropathogenesis-on-chips for neurodegenerative diseases
    Sarnai Amartumur, Huong Mai Nguyen, Thuy Huynh, Testaverde S. Kim, Ran‐Sook Woo, Eungseok Oh, Kyeong Kyu Kim, Luke P. Lee, Chaejeong Heo · 2024 · Nature Communications
22. C9ORF72 repeat expansion in clinical and neuropathologic frontotemporal dementia cohorts
    Carol Dobson‐Stone, Marianne Hallupp, Lauren Bartley, Claire E. Shepherd, Glenda Margaret Halliday, Peter R. Schofield, John R. Hodges, John B. Kwok · 2012 · Neurology
23. Brain distribution of dipeptide repeat proteins in frontotemporal lobar degeneration and motor neurone disease associated with expansions in C9ORF72
    Yvonne S. Davidson, Holly Barker, Andrew Robinson, J. C. Thompson, Jenny Harris, Claire Troakes, Bradley N. Smith, Safa Al‐Saraj, Christopher E. Shaw, Sara J. Rollinson et al. · 2014 · Acta Neuropathologica Communications
24. Reappraisal of TDP-43 pathology in FTLD-U subtypes
    Ian R. Mackenzie, Manuela Neumann · 2017 · Acta Neuropathologica
25. Regulatory Roles of Long Non-Coding RNAs in the Central Nervous System and Associated Neurodegenerative Diseases
    Zhenzhen Quan, Da Zheng, Hong Qing · 2017 · Frontiers in Cellular Neuroscience
26. Genome-wide identification of the genetic basis of amyotrophic lateral sclerosis
    Sai Zhang, Johnathan Cooper‐Knock, Annika K K Weimer, Minyi Shi, Tobias Moll, Jack N.G. Marshall, Calum Harvey, Helia Ghahremani Nezhad, John Franklin, Cleide Dos Santos Souza et al. · 2022 · Neuron
27. Screening of CHCHD10 in a French cohort confirms the involvement of this gene in frontotemporal dementia with amyotrophic lateral sclerosis patients
    Annabelle Chaussenot, Isabelle Le Ber, Samira Ait-El-Mkadem, Agnès Camuzat, Anne Langlois de Septenville, Sylvie Bannwarth, Emmanuelle C. Genin, Valérie Serre, Gaëlle Augé, Alexis Brice et al. · 2014 · Neurobiology of Aging
28. What causes amyotrophic lateral sclerosis?
    Sarah Opie-Martin, Ahmad Al Khleifat, Ammar Al‐Chalabi · 2017 · F1000Research
29. The Hairpin Form of r(G4C2)exp in c9ALS/FTD Is Repeat-Associated Non-ATG Translated and a Target for Bioactive Small Molecules
    Zi-Fu Wang, Andrei Ursu, Jessica L. Childs‐Disney, Rea Guertler, Wang-Yong Yang, Viachaslau Bernat, Suzanne G. Rzuczek, Rita Fuerst, Yong‐Jie Zhang, Tania F. Gendron et al. · 2018 · Cell chemical biology
30. The involvement of stress granules in aging and aging‐associated diseases
    Xiuling Cao, Xuejiao Jin, Beidong Liu · 2020 · Aging Cell
31. Frontotemporal Dementias
    Elizabeth C. Finger · 2016 · CONTINUUM Lifelong Learning in Neurology
32. Longitudinal neuroimaging and neuropsychological profiles of frontotemporal dementia with C9ORF72 expansions
    Mahoney, Colin J, Downey, Laura E, Ridgway, Gerard R, Beck, Jon, Clegg, Shona, Blair, Melanie, Finnegan, Sarah, Leung, Kelvin K, Yeatman, Tom, Golden, Hannah et al. · 2012 · Alzheimer's Research & Therapy
33. Amyotrophic lateral sclerosis: Current perspectives from basic research to the clinic
    Renzo Mancuso, Xavier Navarro · 2015 · Progress in Neurobiology
34. Repeat associated non-ATG (RAN) translation: new starts in microsatellite expansion disorders
    John Douglas Cleary, Laura P.W. Ranum · 2014 · Current Opinion in Genetics & Development
35. ALS biomarkers for therapy development: State of the field and future directions
    Michael G Benatar, Khrista Boylan, Andreas Jeromin, Seward B. Rutkove, James D. Berry, Nazem Atassi, Lucie I. Bruijn · 2015 · Muscle & Nerve
36. Transcranial Magnetic Stimulation for the Assessment of Neurodegenerative Disease
    Steve Vucic, Matthew C. Kiernan · 2016 · Neurotherapeutics
37. ALS/FTLD: experimental models and reality
    Rachel H. Tan, Yazi Diana Ke, Lars Matthias Ittner, Glenda Margaret Halliday · 2017 · Acta Neuropathologica
38. Protective paraspeckle hyper-assembly downstream of TDP-43 loss of function in amyotrophic lateral sclerosis
    Tatyana A. Shelkovnikova, Michail S. Kukharsky, Haiyan An, Pasquale Dimasi, Svetlana Alexeeva, Osman Shabir, Paul Roy Heath, Vladimir L. Buchman · 2018 · Molecular Neurodegeneration
39. Nuclear poly(ADP-ribose) activity is a therapeutic target in amyotrophic lateral sclerosis
    Leeanne McGurk, Jelena Mojsilovic‐Petrovic, Vivianna M. Van Deerlin, James Shorter, Robert Gordon Kalb, V. M. Lee, John Q. Trojanowski, E. B. Lee, Nancy M. Bonini · 2018 · Acta Neuropathologica Communications
40. Disease-modifying therapies in amyotrophic lateral sclerosis
    Adriano Chiò, Letizia Mazzini, Gabriele Mora · 2020 · Neuropharmacology
41. Patterns of microglial cell activation in frontotemporal lobar degeneration
    Lant, Suzannah B., Robinson, Andrew C., Thompson, Jennifer C., Rollinson, Sara, Pickering‐Brown, Stuart, Snowden, Julie S., Davidson, Yvonne S., Gerhard, Alexander, Mann, David M. A. · 2014 · Neuropathology and Applied Neurobiology
42. Plasma neurofilament light for prediction of disease progression in familial frontotemporal lobar degeneration
    Rojas, Julio C., Wang, Ping, Staffaroni, Adam M., Heller, Carolin, Cobigo, Yann, Wolf, Amy, Goh, Sheng-Yang M., Ljubenkov, Peter A., Heuer, Hilary W., Fong, Jamie C. et al. · 2021 · Neurology
43. 25 years of neuroimaging in amyotrophic lateral sclerosis
    Bradley R. Foerster, Robert C. Welsh, Eva L. Feldman · 2013 · Nature Reviews Neurology
44. Nuclear accumulation of mRNAs underlies G4C2 repeat-induced translational repression in a cellular model of C9orf72 ALS
    Simona Rossi, Alessia Serrano, Valeria Gerbino, Alessandra Giorgi, Laura Di Francesco, Monica Nencini, Francesca Bozzo, Maria Eugenia Schininà, Claudia Bagni, Gianluca Cestra et al. · 2015 · Journal of Cell Science
45. TDP-43 proteinopathies: pathological identification of brain regions differentiating clinical phenotypes
    Rachel H. Tan, Jillian J. Kril, Manaal Fatima, Andrew B. McGeachie, Heather McCann, Claire E. Shepherd, Shelley L. Forrest, Andrew J. Affleck, John B. Kwok, John R. Hodges et al. · 2015 · Brain
46. Protein folding alterations in amyotrophic lateral sclerosis
    Sonam Parakh, Julie D. Atkin · 2016 · Brain Research
47. Tdp-43 cryptic exons are highly variable between cell types
    Yun Ha Jeong, Jonathan P. Ling, Sophie Z. Lin, Aneesh Donde, Kerstin E. Braunstein, Elisa Majounie, Bryan J. Traynor, Katherine D. LaClair, Thomas E. Lloyd, Philip C. Wong · 2017 · Molecular Neurodegeneration
48. Characterization of a Human-Specific Tandem Repeat Associated with Bipolar Disorder and Schizophrenia
    Janet H. T. Song, Craig B. Lowe, David M. Kingsley · 2018 · The American Journal of Human Genetics
49. TDP-43 skeins show properties of amyloid in a subset of ALS cases
    John L. Robinson, Felix Geser, Anna Stieber, Mfon E. Umoh, Linda K. Kwong, Vivianna M. Van Deerlin, Virginia M.‐Y. Lee, John Q. Trojanowski · 2012 · Acta Neuropathologica
50. Phosphorylated neurofilament heavy chain: A biomarker of survival for C9ORF 72‐associated amyotrophic lateral sclerosis
    Tania F. Gendron, Lillian M. Daughrity, Michael G. Heckman, Nancy N. Diehl, Joanne Wuu, Timothy M. Miller, Pau Pástor, John Q. Trojanowski, Murray Grossman, James D. Berry et al. · 2017 · Annals of Neurology
51. miR-338-3p is over-expressed in blood, CFS, serum and spinal cord from sporadic amyotrophic lateral sclerosis patients
    Bruna De Felice, Anna Annunziata, Giuseppe Fiorentino, Marco Borra, Elio Biffali, Cinzia Coppola, Roberto Cotrufo, Johannes Brettschneider, Maria Luisa Giordana, Tamás Dalmay et al. · 2014 · Neurogenetics
52. Investigation of C9orf72 in 4 Neurodegenerative Disorders
    Zhengrui Xi, Lorne H. Zinman, Yakov Grinberg, Danielle Moreno, Christine Sato, Juan M. Bilbao, Mahdi Ghani, Isabel Hernández, Agustı́n Ruiz, Merçé Boada et al. · 2012 · Archives of Neurology
53. Characterization of the repeat expansion size in C9orf72 in amyotrophic lateral sclerosis and frontotemporal dementia
    Oriol Dols‐Icardo, Alberto García‐Redondo, Ricard Rojas‐García, Raquel Sánchez‐Valle, A. Noguera, Estrella Gómez‐Tortosa, Pau Pástor, I. Hernandez, Jesús Esteban‐Pérez, Marc Suárez‐Calvet et al. · 2013 · Human Molecular Genetics
54. Membrane Trafficking in Autophagy
    Kristiane Søreng, Thomas P. Neufeld, Anne Simonsen · 2017 · International review of cytology
55. Autophagy as a common pathway in amyotrophic lateral sclerosis
    Dao K.H. Nguyen, Ravi Thombre, Jiou Wang · 2018 · Neuroscience Letters
56. Nucleolar stress: From development to cancer
    M. Carmen Lafita‐Navarro, Maralice Conacci‐Sorrell · 2022 · Seminars in Cell and Developmental Biology
57. Distinct clinical and pathological phenotypes in frontotemporal dementia associated with MAPT, PGRN and C9orf72 mutations
    Julie S. Snowden, Jennifer Adams, Jennifer Harris, J. C. Thompson, Sara J. Rollinson, Anna M. T. Richardson, Matthew S. Jones, D. Neary, David M. A. Mann, Stuart M. Pickering-Brown · 2015 · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
58. Identification of Therapeutic Targets for Amyotrophic Lateral Sclerosis Using PandaOmics – An AI-Enabled Biological Target Discovery Platform
    Pun, Frank W., Liu, Bonnie Hei Man, Long, Xi, Leung, Hoi Wing, Leung, Geoffrey Ho Duen, Mewborne, Quinlan T., Gao, Junli, Shneyderman, Anastasia, Ozerov, Ivan V., Wang, Ju et al. · 2022 · Frontiers in Aging Neuroscience
59. Role of mitochondria in mutant SOD1 linked amyotrophic lateral sclerosis
    Wenzhi Tan, Piera Pasinelli, Davide Trotti · 2014 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
60. Neuropsychiatric changes precede classic motor symptoms in ALS and do not affect survival
    Eneida Mioshi, Jashelle Caga, Patricia Lillo, Sharpley Hsieh, Eleanor Ramsey, Emma M. Devenney, Michael Hornberger, John R. Hodges, Matthew C. Kiernan · 2013 · Neurology
61. What we know about TMEM106B in neurodegeneration
    Alexandra M. Nicholson, Rosa Rademakers · 2016 · Acta Neuropathologica
62. Novel antibodies reveal presynaptic localization of C9orf72 protein and reduced protein levels in C9orf72 mutation carriers
    P. Frick, C. Sellier, I. Mackenzie, Chieh-Yu Cheng, Julie Tahraoui-Bories, C. Martinat, R. Pasterkamp, J. Prudlo, D. Edbauer, M. Oulad-Abdelghani et al. · 2018 · Acta Neuropathologica Communications
63. Molecular analysis and biochemical classification of TDP-43 proteinopathy
    Hiroshi Tsuji, Tetsuaki Arai, Fuyuki Kametani, Takashi Nonaka, Makiko Yamashita, Masami Masuda‐Suzukake, Masato Hosokawa, Mari Yoshida, Hiroyuki Hatsuta, Masaki Takao et al. · 2012 · Brain
64. Cerebellar c9RAN proteins associate with clinical and neuropathological characteristics of C9ORF72 repeat expansion carriers
    Gendron, Tania F., van Blitterswijk, Marka, Bieniek, Kevin F., Daughrity, Lillian M., Jiang, Jie, Rush, Beth K., Pedraza, Otto, Lucas, John A., Murray, Melissa E., Desaro, Pamela et al. · 2015 · Acta Neuropathologica
65. C9ORF72 Repeat Expansions in the Frontotemporal Dementias Spectrum of Diseases: A Flow-chart for Genetic Testing
    Isabelle Le Ber, Agnès Camuzat, Léna Guillot‐Noël, Didier Hannequin, Lucette Lacomblez, Véronique Golfier, Michèle Puel, Olivier Martinaud, Vincent Deramecourt, Sophie Rivaud-Péchoux et al. · 2013 · Journal of Alzheimer s Disease
66. Translational potential of astrocytes in brain disorders
    Alexei Verkhratsky, Luca Steardo, Vladimir Parpura, Vedrana Montana · 2015 · Progress in Neurobiology
67. Fluid-Based Biomarkers for Amyotrophic Lateral Sclerosis
    Lucas T. Vu, Robert P. Bowser · 2016 · Neurotherapeutics
68. Stress granules at the intersection of autophagy and ALS
    Zachary T. Monahan, Frank P. Shewmaker, Udai Bhan Pandey · 2016 · Brain Research
69. Cellular Regulation of Amyloid Formation in Aging and Disease
    Esther Stroo, Mandy Koopman, Ellen A. A. Nollen, Alejandro Mata‐Cabana · 2017 · Frontiers in Neuroscience
70. Past, Present, and Future of Non-invasive Brain Stimulation Approaches to Treat Cognitive Impairment in Neurodegenerative Diseases: Time for a Comprehensive Critical Review
    Clara Sanches, Chloé Stengel, Juliette Godard, Justine Mertz, Marc Teichmann, Raffaella Migliaccio, Antoni Valero‐Cabré · 2021 · Frontiers in Aging Neuroscience
71. Immunotherapies for Neurodegenerative Diseases
    Ibrahim Mortada, Raymond Farah, Sanaa M. Nabha, David M. Ojcius, Youssef Fares, Wassim Youssef Almawi, Najwane Said Sadier · 2021 · Frontiers in Neurology
72. SOD1 Aggregation and ALS: Role of Metallation States and Disulfide Status
    Yuewei Sheng, Madhuri Chattopadhyay, Julian P. Whitelegge, Joan Selverstone Valentine · 2013 · Current Topics in Medicinal Chemistry
73. Antisense drugs make sense for neurological diseases
    Bennett, C. Frank, Kordasiewicz, Holly B., Cleveland, Don W. · 2021 · Annual Review of Pharmacology and Toxicology
74. The role of the immune system in neurodegenerative disorders: Adaptive or maladaptive?
    Doty, Kevin R., Guillot-Sestier, Marie-Victoire, Town, Terrence · 2015 · Brain Research
75. Molecular classification of amyotrophic lateral sclerosis by unsupervised clustering of gene expression in motor cortex
    Eleonora Aronica, Frank Baas, Anand M. Iyer, Anneloor L.M.A. ten Asbroek, Giovanna Morello, Sebastiano Cavallaro · 2014 · Neurobiology of Disease
76. Role of FET proteins in neurodegenerative disorders
    Francesca Svetoni, Paola Frisone, Maria Paola Paronetto · 2016 · RNA Biology
77. Axon-Seq Decodes the Motor Axon Transcriptome and Its Modulation in Response to ALS
    Jik Nijssen, Julio Aguila Benitez, Rein I. Hoogstraaten, Nigel Kee, Eva Hedlund · 2018 · Stem Cell Reports
78. Risk factors and emerging therapies in amyotrophic lateral sclerosis
    Nowicka, Natalia, Juranek, Jakub, Juranek, Judyta K., Wojtkiewicz, Joanna · 2019 · International Journal of Molecular Sciences
79. Mutant TDP-43 Causes Early-Stage Dose-Dependent Motor Neuron Degeneration in a TARDBP Knockin Mouse Model of ALS
    Sarah Y. Ebstein, Ilona Yagudayeva, Neil A. Shneider · 2019 · Cell Reports
80. Distinct molecular patterns of TDP-43 pathology in Alzheimer’s disease: relationship with clinical phenotypes
    Sandra O. Tomé, Rik R. Vandenberghe, Simona Ospitalieri, Evelien Van Schoor, Thomas Tousseyn, Markus Otto, Christine A. F. Von Arnim, Dietmar Rudolf Thal · 2020 · Acta Neuropathologica Communications
81. Physical exercise is a risk factor for amyotrophic lateral sclerosis: Convergent evidence from Mendelian randomisation, transcriptomics and risk genotypes
    Thomas Henry Julian, Nicholas Glascow, A Dylan Fisher Barry, Tobias Moll, Calum Harvey, Yann C. Klimentidis, Michelle Newell, Sai Zhang, Michael P. Snyder, Johnathan Cooper‐Knock et al. · 2021 · EBioMedicine
82. Neuropathology and emerging biomarkers in corticobasal syndrome
    Shunsuke Koga, Keith A. Josephs, Ikuko Aiba, Mari Yoshida, Dennis W. Dickson · 2022 · Journal of Neurology Neurosurgery & Psychiatry
83. Effect of Presymptomatic Body Mass Index and Consumption of Fat and Alcohol on Amyotrophic Lateral Sclerosis
    Mark H. B. Huisman, Meinie Seelen, Perry T.C. van Doormaal, Sonja W. de Jong, Jeanne H. M. de Vries, Anneke J. van der Kooi, Marianne de Visser, Helenius Jurgen Schelhaas, Leonard H. van den Berg, Jan Herman Veldink · 2015 · JAMA Neurology
84. The El Escorial criteria: Strengths and weaknesses
    Federica Agosta, Ammar Al‐Chalabi, Massimo Filippi, Orla M. Hardiman, Ryuji Kaji, Vincent Meininger, Imaharu Nakano, Pamela J. Shaw, Jeremy M. Shefner, Leonard H. van den Berg et al. · 2014 · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
85. Focality, stochasticity and neuroanatomic propagation in ALS pathogenesis
    John Ravits · 2014 · Experimental Neurology
86. The genetics of amyotrophic lateral sclerosis: current insights
    Janine Kirby, Afnan Al Sultan, Rachel Waller, Paul Roy Heath · 2016 · Degenerative Neurological and Neuromuscular Disease
87. Axonal transport defects are a common phenotype in Drosophila models of ALS
    Katie R. Baldwin, Vinay K. Godena, Victoria L. Hewitt, Alexander J. Whitworth · 2016 · Human Molecular Genetics
88. Sphingosine-1-phosphate receptor therapies: Advances in clinical trials for CNS-related diseases
    Sinéad A. O’Sullivan, Kumlesh Kumar Dev · 2016 · Neuropharmacology
89. TBK1 Mutation Spectrum in an Extended European Patient Cohort with Frontotemporal Dementia and Amyotrophic Lateral Sclerosis
    Julie van der Zee, Ilse Gijselinck, Sara Van Mossevelde, Federica Perrone, Lubina Dillen, Bavo Heeman, Veerle Bäumer, Sebastiaan Engelborghs, Jan De Bleecker, Jonathan Baets et al. · 2016 · Human Mutation
90. Edaravone (Radicava): A Novel Neuroprotective Agent for the Treatment of Amyotrophic Lateral Sclerosis.
    Martin Paspe Cruz · 2018 · PubMed Central
91. Targeted next-generation sequencing panels in the diagnosis of Charcot-Marie-Tooth disease
    Andrea Cortese, Janel E. Wilcox, James M. Polke, Roy Poh, Mariola Skorupinska, Alexander Martin Rossor, Matilde Laurá, Pedro José Tomaselli, Henry Houlden, Michael E. Shy et al. · 2019 · Neurology
92. Advances in molecular pathology, diagnosis, and treatment of amyotrophic lateral sclerosis
    Ilieva, Hristelina, Vullaganti, Mithila, Kwan, Justin · 2023 · BMJ
93. Iron and Neurodegeneration: Is Ferritinophagy the Link?
    Giorgio Biasiotto, Diego Di Lorenzo, Silvana Archetti, Isabella Zanella · 2015 · Molecular Neurobiology
94. The distinct genetic pattern of ALS in Turkey and novel mutations
    Aslıhan Özoğuz, Özgün Uyan, Güneş Birdal, Ceren Tunca, Ece Kartal, Suna Lahut, Özgür Ömür, Zeynep Sena Ağım, Aslı Gündoğdu Eken, Nesli-Ece Şen et al. · 2015 · Neurobiology of Aging
95. The disease intersection of susceptibility and exposure: Chemical exposures and neurodegenerative disease risk
    Caroline M. Tanner, Samuel M. Goldman, G. Webster Ross, Stephen J. Grate · 2014 · Alzheimer s & Dementia
96. The Role of RNA in Biological Phase Separations
    Marta M. Fay, Paul Anderson · 2018 · Journal of Molecular Biology
97. Astrocyte adenosine deaminase loss increases motor neuron toxicity in amyotrophic lateral sclerosis
    Scott P. Allen, Benjamin Hall, Lydia M. Castelli, Laura I. Francis, Ryan Woof, Alexandros Siskos, Eirini Kouloura, Elizabeth Gray, Alexander G. Thompson, Kevin Talbot et al. · 2019 · Brain
98. Newest Methods for Detecting Structural Variations
    Wouter De Coster, Christine Van Broeckhoven · 2019 · Trends in biotechnology
99. The role of RNA G‐quadruplexes in human diseases and therapeutic strategies
    Prakash Kharel, Sumirtha Balaratnam, Nathan Beals, Soumitra Basu · 2019 · Wiley Interdisciplinary Reviews - RNA
100. Antibody Therapy Targeting RAN Proteins Rescues C9 ALS/FTD Phenotypes in C9orf72 Mouse Model
     Lien Nguyen, Fabio Montrasio, Amrutha Pattamatta, Solaleh Khoramian Tusi, Olgert Bardhi, Kevin D. Meyer, Lindsey R. Hayes, Katsuya Nakamura, Mónica Báñez-Coronel, Alyssa N. Coyne et al. · 2019 · Neuron